Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLEU NASDAQ:CEPT NYSE:MSB NASDAQ:VACH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLEUbleuacacia$11.03$11.05$10.70▼$11.59$83.39M0.013,271 shsN/ACEPTCantor Equity Partners II$11.66-0.3%$11.26$10.61▼$12.49$356.56MN/A322,516 shs202,176 shsMSBMesabi Trust$25.28-1.0%$25.11$15.93▼$37.00$330.69M0.5442,833 shs8,400 shsVACHVoyager Acquisition$10.39-0.2%$10.35$9.95▼$11.20$328.53MN/A117,638 shs7,829 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLEUbleuacacia0.00%0.00%0.00%0.00%+2.60%CEPTCantor Equity Partners II+2.09%+9.24%+2.72%+1,169,999,900.00%+1,169,999,900.00%MSBMesabi Trust+1.64%+4.24%+4.19%-10.54%+42.95%VACHVoyager Acquisition+0.04%+0.04%+0.18%+1.55%+1,039,899,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLEUbleuacaciaN/AN/AN/AN/AN/AN/AN/AN/ACEPTCantor Equity Partners IIN/AN/AN/AN/AN/AN/AN/AN/AMSBMesabi Trust0.8124 of 5 stars0.01.02.50.02.00.01.3VACHVoyager AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLEUbleuacacia 0.00N/AN/AN/ACEPTCantor Equity Partners II 0.00N/AN/AN/AMSBMesabi Trust 0.00N/AN/AN/AVACHVoyager Acquisition 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLEUbleuacaciaN/AN/A$0.56 per share19.70($1.64) per shareN/ACEPTCantor Equity Partners IIN/AN/AN/AN/AN/AN/AMSBMesabi Trust$23.79M13.94$7.20 per share3.51$1.78 per share14.20VACHVoyager AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLEUbleuacacia$3.86MN/A58.05∞N/AN/A-6.04%4.62%N/ACEPTCantor Equity Partners IIN/AN/A0.00∞N/AN/AN/AN/AN/AMSBMesabi Trust$93.27M$7.123.54∞N/A96.23%233.00%145.93%9/4/2025 (Estimated)VACHVoyager AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ALatest BLEU, CEPT, MSB, and VACH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/12/2025Q1 2026MSBMesabi TrustN/A$0.28N/A$0.28N/A$4.74 million4/24/2025Q4 2025MSBMesabi TrustN/A$0.46N/A$0.46N/A$6.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLEUbleuacaciaN/AN/AN/AN/AN/ACEPTCantor Equity Partners IIN/AN/AN/AN/AN/AMSBMesabi Trust$0.481.90%N/A6.74%N/AVACHVoyager AcquisitionN/AN/AN/AN/AN/ALatest BLEU, CEPT, MSB, and VACH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/23/2025MSBMesabi Trust$0.568.05%4/30/20255/1/20255/20/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLEUbleuacaciaN/A0.040.04CEPTCantor Equity Partners IIN/AN/AN/AMSBMesabi TrustN/A3.513.51VACHVoyager AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLEUbleuacacia13.89%CEPTCantor Equity Partners IIN/AMSBMesabi TrustN/AVACHVoyager AcquisitionN/AInsider OwnershipCompanyInsider OwnershipBLEUbleuacacia0.94%CEPTCantor Equity Partners IIN/AMSBMesabi Trust0.26%VACHVoyager AcquisitionN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLEUbleuacacia47.56 million7.49 millionNot OptionableCEPTCantor Equity Partners II230.58 millionN/AN/AMSBMesabi TrustN/A13.12 million13.09 millionOptionableVACHVoyager AcquisitionN/A31.62 millionN/AN/ABLEU, CEPT, MSB, and VACH HeadlinesRecent News About These CompaniesVERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC5 hours ago | globenewswire.comXlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4July 17 at 3:28 AM | pharmiweb.comPVERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SECJuly 17 at 2:00 AM | globenewswire.comWealthspring Capital LLC Sells 24,668 Shares of Voyager Acquisition Corp. (NASDAQ:VACH)July 15 at 9:28 AM | marketbeat.comVACH Voyager Acquisition Corp. - Seeking AlphaJuly 10, 2025 | seekingalpha.comVoyager Acquisition (NASDAQ:VACH) Trading Down 0.1% - Here's WhyJune 28, 2025 | marketbeat.comVoyager Acquisition Corp. Cl A (VACH) Stock Price Today - WSJJune 27, 2025 | wsj.comSpace Firm Voyager Technologies Surges 139% After Upsized IPOJune 11, 2025 | msn.comVoyager launches IPO with $1.6 billion valuation targetJune 3, 2025 | spacenews.comSVERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology PlatformMay 29, 2025 | globenewswire.comVERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology PlatformMay 29, 2025 | globenewswire.comVERAXA Biotech Appoints Rick Austin as Chief Scientific OfficerMay 20, 2025 | globenewswire.comVERAXA Biotech Appoints Rick Austin as Chief Scientific OfficerMay 20, 2025 | manilatimes.netMVoyager Acquisition Corp.: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 6, 2025 | finanznachrichten.deVERAXA Biotech GmbH: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 5, 2025 | finanznachrichten.deVeraxa to go public in $1.6bn SPAC deal with VoyagerApril 23, 2025 | msn.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVeraxa Biotech to merge with SPAC Voyager in $1.64 billion dealApril 23, 2025 | msn.comFrom Lab to Unicorn: Xlife Sciences AG Portfolio Company VERAXA Biotech AG to merge with Voyager Acquisition Corp. listed on NASDAQApril 23, 2025 | markets.businessinsider.comXlife Sciences’ VERAXA Biotech to Merge with Voyager Acquisition Corp.April 23, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseQualcomm’s Hold Rating Misses Strong Growth StoryBy Jeffrey Neal Johnson | July 4, 2025View Qualcomm’s Hold Rating Misses Strong Growth StoryBLEU, CEPT, MSB, and VACH Company Descriptionsbleuacacia NASDAQ:BLEUbleuacacia ltd does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of premium branded consumer retail. The company was incorporated in 2021 and is based in New York, New York.Cantor Equity Partners II NASDAQ:CEPT$11.66 -0.04 (-0.34%) As of 12:52 PM EasternCantor Equity Partners II, Inc. is a blank check company. The company was founded on November 11, 2020 and is headquartered in New York, NYMesabi Trust NYSE:MSB$25.28 -0.26 (-1.02%) As of 01:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. Mesabi Trust was founded in 1961 and is based in New York, New York.Voyager Acquisition NASDAQ:VACH$10.39 -0.02 (-0.19%) As of 12:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Voyager Acquisition Corp. is a blank check company. It formed for the purpose of merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Voyager Acquisition Corp. is based in BROOKLYN, N.Y. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
